Oncology Market Insights Lead

Ipsen Pharma (SAS); United States; On-site; USD 55,000 - 85,000; Full time

Job summary

Ipsen Pharma (SAS) in the United States seeks a VIE Oncology Business Insights Manager to support market research and strategic insights within the US Oncology unit. You will work with Marketing, Finance, Sales, Analytics, Medical and Commercial Excellence to translate data into business actions.

The role includes managing research projects, analyzing trends, monitoring competitors, coordinating with external vendors, and delivering clear presentations to stakeholders.

Qualifications

• Bachelor's or Master's in Business, Marketing, Life Sciences, or related field.
• 2 years of pharma or life sciences experience preferred.
• Interest in Oncology and pharmaceutical industry.
• Ability to translate data into business recommendations.
• Strong communication and presentation skills.

Responsibilities

• Support development and execution of market research projects.
• Analyze market trends, customer behavior, and performance data.
• Monitor competitive landscape and scientific developments.
• Collaborate with Marketing, Finance, Sales, Analytics, Medical, and Commercial Excellence teams.
• Coordinate with external vendors to deliver research programs.
• Translate findings into actionable insights and recommendations.
• Prepare and deliver clear presentations of key findings.

Skills

Fluent English

Analytical thinking

Project management

Cross-functional collaboration

Education

Bachelor's or Master's degree

Tools

Excel

PowerPoint

Job description

Ipsen Pharma (SAS) in the United States seeks a VIE Oncology Business Insights Manager to support market research and strategic insights within the US Oncology unit. You will work with Marketing, Finance, Sales, Analytics, Medical and Commercial Excellence to translate data into business actions.

The role includes managing research projects, analyzing trends, monitoring competitors, coordinating with external vendors, and delivering clear presentations to stakeholders.